Page last updated: 2024-10-30

metformin and Chemical and Drug Induced Liver Injury

metformin has been researched along with Chemical and Drug Induced Liver Injury in 49 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Chemical and Drug Induced Liver Injury: A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment.

Research Excerpts

ExcerptRelevanceReference
"To report a case of idiosyncratic hepatotoxicity associated with metformin in the treatment of type 2 diabetes with nonalcoholic fatty liver disease (NAFLD)."7.76Hepatotoxicity associated with metformin therapy in treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease. ( Bachyrycz, AM; Cone, CJ; Murata, GH, 2010)
"The aim of this study was to assess the incidence of liver failure in association with antidiabetic treatment using pioglitazone vs."7.73Comparison of pioglitazone with other antidiabetic drugs for associated incidence of liver failure: no evidence of increased risk of liver failure with pioglitazone. ( Iyer, S; Perez, A; Rajagopalan, R, 2005)
"Metformin is an oral antidiabetic agent frequently used to manage type II diabetes."5.35[Constitutional syndrome associated to metformin induced hepatotoxicity]. ( Angueira Lapeña, T; Arranz de la Mata, G; Boixeda de Miquel, D; de la Poza Gómez, G; Rivero Fernández, M; Vázquez Romero, M, 2008)
" We aimed to elucidate the mechanism of JLD treatment, in comparison to metformin treatment, on ameliorating insulin sensitivity in insulin resistant rats and to reveal its anti-oxidant properties."3.81Jinlida reduces insulin resistance and ameliorates liver oxidative stress in high-fat fed rats. ( Duan, L; Li, L; Li, X; Liu, Y; Song, A; Song, G; Wang, C; Wang, Y; Yu, X; Zang, S; Zhu, Y, 2015)
"To report a case of idiosyncratic hepatotoxicity associated with metformin in the treatment of type 2 diabetes with nonalcoholic fatty liver disease (NAFLD)."3.76Hepatotoxicity associated with metformin therapy in treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease. ( Bachyrycz, AM; Cone, CJ; Murata, GH, 2010)
"In this patient, lactic acidosis was promoted by erlotinib-related hepatitis with initial liver failure (decreased lactate clearance), concomitant metformin treatment (increased lactate production), and acute renal deterioration (metformin accumulation)."3.75Erlotinib-induced hepatitis complicated by fatal lactic acidosis in an elderly man with lung cancer. ( Fimognari, FL; Franco, A; Pastorelli, R; Pellegrinotti, M; Repetto, L, 2009)
"The aim of this study was to assess the incidence of liver failure in association with antidiabetic treatment using pioglitazone vs."3.73Comparison of pioglitazone with other antidiabetic drugs for associated incidence of liver failure: no evidence of increased risk of liver failure with pioglitazone. ( Iyer, S; Perez, A; Rajagopalan, R, 2005)
" However, its therapeutic application is restricted by its adverse effects, particularly hepatotoxicity."1.91Combination of metformin and hesperidin mitigates cyclophosphamide-induced hepatotoxicity. Emerging role of PPAR-γ/Nrf-2/NF-κB signaling pathway. ( El-Beheiry, KM; El-Masry, TA; El-Sayed El-Sayad, M; Elsisi, AE, 2023)
"The changes that follow liver fibrosis were assessed by measurement of hepatic enzymes (ALT, AST and ALP), histopathological examination using hematoxylin and eosin stain, special stains, and α-smooth muscle actin (α-SMA) immunostaining, measuring oxidative stress markers (MDA, GSH, NOx and MnSOD) and transforming growth factor-beta 1 (TGF-β1) in liver."1.72Metformin versus silymarin as hepatoprotective agents in mice fibrotic model caused by carbon tetrachloride. ( Ahmed, AA; Ahmed, MA; El-Bakry, MH; Hasan, A; Omar, ZMM, 2022)
"Metformin (1 mmol/L) was protective against DF-induced apoptosis in hepatocytes."1.62Metformin protects against diclofenac-induced toxicity in primary rat hepatocytes by preserving mitochondrial integrity via a pathway involving EPAC. ( Alieva, T; Arroyave Ospina, JC; Buist-Homan, M; Cheng, X; Geng, Y; Lezoualc'h, F; Mora, FAA; Moshage, H; Musheshe, N; Rodrigo, JA; Schmidt, M; Soto, JM, 2021)
"Metformin is currently the most prescribed oral agent for diabetes treatment; however the overdose or long-term use may cause some severe side effects such as liver injury."1.51A Turn-On Optoacoustic Probe for Imaging Metformin-Induced Upregulation of Hepatic Hydrogen Sulfide and Subsequent Liver Injury. ( Chen, J; Sun, L; Wu, S; Wu, Y; Zeng, F; Zhong, J, 2019)
"Arsenic trioxide (ATO) is a well-accepted chemotherapy agent in managing promyelocytic leukemia."1.46Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I. ( Chen, K; Feng, T; Ling, S; Liu, J; Liu, P; Shan, Q; Song, P; Xiang, P; Xie, H; Xu, X; Zhang, X; Zheng, S; Zhou, L, 2017)
"Metformin + Con A-treated mice had elevated serum levels of pro-inflammatory cytokines TNF-α and IFN-γ, accompanied by a massive mononuclear cell infiltration in the liver."1.42Metformin aggravates immune-mediated liver injury in mice. ( Arsenijevic, N; Jakovljevic, V; Lukic, ML; Micic, D; Milovanovic, M; Misirkic, M; Paunovic, V; Simovic Markovic, B; Stojanovic, M; Trajkovic, V; Volarevic, V; Vucicevic, L, 2015)
"Metformin pretreatment protected against APAP toxicity with decreased liver damage, and inhibited APAP-induced prolonged hepatic JNK phosphorylation in WT mice."1.42Metformin ameliorates acetaminophen hepatotoxicity via Gadd45β-dependent regulation of JNK signaling in mice. ( Choi, DH; Choi, HS; Hwang, JH; Kim, DK; Kim, KS; Kim, YH; Lee, CH; Noh, JR; Tadi, S; Yim, YH, 2015)
"Metformin is a commonly used anti-diabetic drug with AMP-activated protein kinase (AMPK)-dependent hypoglycemic activities."1.40Involvement of catalase in the protective benefits of metformin in mice with oxidative liver injury. ( Ai, Q; Dai, J; Deng, X; Jia, M; Jing, Y; Lin, L; Liu, M; Wan, J; Wu, K; Zhang, L, 2014)
"Metformin pretreatment alleviated the activity of serum enzymes, and attenuated histopathological lesions caused by LPS/D-GalN injections."1.40Antidiabetic drug metformin is effective on the metabolism of asymmetric dimethylarginine in experimental liver injury. ( Bal, F; Bekpinar, S; Gurdol, F; Kusku-Kiraz, Z; Önder, S; Unlucerci, Y; Uysal, M, 2014)
"Metformin is a first-line antidiabetic drug in type 2 diabetes for its hypoglycemic activity, but recently researches also revealed the anti-inflammatory properties of metformin."1.38Antidiabetic drug metformin alleviates endotoxin-induced fulminant liver injury in mice. ( Ge, P; Li, H; Li, L; Wan, J; Yuan, H; Zhang, L; Zheng, W, 2012)
" An understanding of structure-activity relationships (SARs) of chemicals can make a significant contribution to the identification of potential toxic effects early in the drug development process and aid in avoiding such problems."1.36Developing structure-activity relationships for the prediction of hepatotoxicity. ( Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ, 2010)
"Metformin is an oral biguanide widely used in the management of patients with type 2 diabetes."1.36[Metformin-associated hepatotoxicity]. ( Amores-Arriaga, B; de Escalante-Yangüela, B; Martín-Fortea, P; Navarro-Aguilar, ME; Olivera-González, S; Velilla-Soriano, C, 2010)
"Metformin is an oral antidiabetic agent frequently used to manage type II diabetes."1.35[Constitutional syndrome associated to metformin induced hepatotoxicity]. ( Angueira Lapeña, T; Arranz de la Mata, G; Boixeda de Miquel, D; de la Poza Gómez, G; Rivero Fernández, M; Vázquez Romero, M, 2008)
" The probability of an adverse drug reaction (ADR), as assessed using the Naranjo ADR probability scale, in this case was 4 (probable)."1.33Possible metformin-induced hepatotoxicity. ( Kutoh, E, 2005)
"Acute liver failure was defined as acute liver disease and (1) hepatic encephalopathy, (2) prothrombin time prolongation greater than 3 seconds or international normalized ratio greater than 1."1.32A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents. ( Ackerson, L; Chan, KA; Everhart, JE; Gurwitz, JH; Hurley, JS; Martinson, B; Moseley, RH; Platt, R; Selby, JV; Terrault, N; Truman, A, 2003)

Research

Studies (49)

TimeframeStudies, this research(%)All Research%
pre-19901 (2.04)18.7374
1990's4 (8.16)18.2507
2000's8 (16.33)29.6817
2010's28 (57.14)24.3611
2020's8 (16.33)2.80

Authors

AuthorsStudies
Fourches, D1
Barnes, JC1
Day, NC1
Bradley, P1
Reed, JZ1
Tropsha, A1
Greene, N1
Fisk, L1
Naven, RT1
Note, RR1
Patel, ML1
Pelletier, DJ1
Morgan, RE2
Trauner, M1
van Staden, CJ2
Lee, PH1
Ramachandran, B1
Eschenberg, M1
Afshari, CA2
Qualls, CW1
Lightfoot-Dunn, R1
Hamadeh, HK2
Ekins, S1
Williams, AJ1
Xu, JJ1
Liu, Z3
Shi, Q1
Ding, D2
Kelly, R1
Fang, H1
Tong, W2
Warner, DJ1
Chen, H2
Cantin, LD1
Kenna, JG1
Stahl, S1
Walker, CL1
Noeske, T1
Chen, Y4
Kalyanaraman, N1
Kalanzi, J1
Dunn, RT1
Chen, M1
Suzuki, A1
Thakkar, S1
Yu, K2
Hu, C1
Mora, FAA1
Musheshe, N1
Arroyave Ospina, JC1
Geng, Y1
Soto, JM1
Rodrigo, JA1
Alieva, T1
Buist-Homan, M1
Lezoualc'h, F1
Cheng, X1
Schmidt, M1
Moshage, H1
Omar, ZMM1
Ahmed, AA1
El-Bakry, MH1
Ahmed, MA1
Hasan, A1
El-Beheiry, KM1
El-Sayed El-Sayad, M1
El-Masry, TA1
Elsisi, AE1
Darijani, MH1
Aminzadeh, A1
Rahimi, HR1
Mandegary, A1
Heidari, MR1
Karami-Mohajeri, S1
Jafari, E1
Tripathi, SS1
Singh, S1
Garg, G1
Kumar, R1
Verma, AK1
Singh, AK2
Bissoyi, A1
Rizvi, SI1
Nguépy Keubo, FR1
Mboua, PC1
Djifack Tadongfack, T1
Fokouong Tchoffo, E1
Tasson Tatang, C1
Ide Zeuna, J1
Noupoue, EM1
Tsoplifack, CB1
Folefack, GO1
Kettani, M1
Bandelier, P1
Huo, J1
Li, H5
Yu, D1
Arulsamy, N1
AlAbbad, S1
Sardot, T1
Lekashvili, O1
Decato, D1
Lelj, F1
Alexander Ross, JB1
Rosenberg, E1
Nazir, H1
Muthuswamy, N1
Louis, C1
Jose, S1
Prakash, J1
Buan, MEM1
Flox, C1
Chavan, S1
Shi, X1
Kauranen, P1
Kallio, T1
Maia, G1
Tammeveski, K1
Lymperopoulos, N1
Carcadea, E1
Veziroglu, E1
Iranzo, A1
M Kannan, A1
Arunamata, A1
Tacy, TA1
Kache, S1
Mainwaring, RD1
Ma, M1
Maeda, K1
Punn, R1
Noguchi, S1
Hahn, S3
Iwasa, Y3
Ling, J2
Voccio, JP2
Kim, Y3
Song, J3
Bascuñán, J2
Chu, Y1
Tomita, M1
Cazorla, M1
Herrera, E1
Palomeque, E1
Saud, N1
Hoplock, LB1
Lobchuk, MM1
Lemoine, J1
Li, X11
Henson, MA1
Unsihuay, D1
Qiu, J1
Swaroop, S1
Nagornov, KO1
Kozhinov, AN1
Tsybin, YO1
Kuang, S1
Laskin, J1
Zin, NNINM1
Mohamad, MN1
Roslan, K1
Abdul Wafi, S1
Abdul Moin, NI1
Alias, A1
Zakaria, Y1
Abu-Bakar, N1
Naveed, A1
Jilani, K1
Siddique, AB1
Akbar, M1
Riaz, M1
Mushtaq, Z1
Sikandar, M1
Ilyas, S1
Bibi, I1
Asghar, A1
Rasool, G1
Irfan, M1
Li, XY1
Zhao, S1
Fan, XH1
Chen, KP1
Hua, W1
Liu, ZM1
Xue, XD1
Zhou, B1
Zhang, S2
Xing, YL1
Chen, MA1
Sun, Y1
Neradilek, MB1
Wu, XT1
Zhang, D2
Huang, W1
Cui, Y1
Yang, QQ1
Li, HW1
Zhao, XQ1
Hossein Rashidi, B1
Tarafdari, A1
Ghazimirsaeed, ST1
Shahrokh Tehraninezhad, E1
Keikha, F1
Eslami, B1
Ghazimirsaeed, SM1
Jafarabadi, M1
Silvani, Y1
Lovita, AND1
Maharani, A1
Wiyasa, IWA1
Sujuti, H1
Ratnawati, R1
Raras, TYM1
Lemin, AS1
Rahman, MM1
Pangarah, CA1
Kiyu, A1
Zeng, C2
Du, H1
Lin, D1
Jalan, D1
Rubagumya, F1
Hopman, WM1
Vanderpuye, V1
Lopes, G1
Seruga, B1
Booth, CM1
Berry, S1
Hammad, N1
Sajo, EA1
Okunade, KS1
Olorunfemi, G1
Rabiu, KA1
Anorlu, RI1
Xu, C2
Xiang, Y1
Xu, X2
Zhou, L3
Dong, X1
Tang, S1
Gao, XC1
Wei, CH1
Zhang, RG1
Cai, Q1
He, Y1
Tong, F1
Dong, JH1
Wu, G1
Dong, XR1
Tang, X1
Tao, F1
Xiang, W1
Zhao, Y2
Jin, L1
Tao, H1
Lei, Y1
Gan, H1
Huang, Y1
Chen, L3
Shan, A1
Zhao, H2
Wu, M2
Ma, Q1
Wang, J4
Zhang, E1
Zhang, J3
Li, Y5
Xue, F1
Deng, L1
Liu, L2
Yan, Z2
Wang, Y3
Meng, J1
Chen, G2
Anastassiadou, M1
Bernasconi, G1
Brancato, A1
Carrasco Cabrera, L1
Greco, L1
Jarrah, S1
Kazocina, A1
Leuschner, R1
Magrans, JO1
Miron, I1
Nave, S1
Pedersen, R1
Reich, H1
Rojas, A1
Sacchi, A1
Santos, M1
Theobald, A1
Vagenende, B1
Verani, A1
Du, L1
Liu, X1
Ren, Y1
Li, J7
Li, P1
Jiao, Q1
Meng, P1
Wang, F2
Wang, YS1
Wang, C4
Zhou, X2
Wang, W1
Wang, S2
Hou, J1
Zhang, A1
Lv, B1
Gao, C1
Pang, D1
Lu, K1
Ahmad, NH1
Wang, L1
Zhu, J2
Zhang, L5
Zhuang, T1
Tu, J1
Zhao, Z1
Qu, Y1
Yao, H1
Wang, X5
Lee, DF1
Shen, J3
Wen, L1
Huang, G2
Xie, X1
Zhao, Q1
Hu, W1
Zhang, Y4
Wu, X1
Lu, J2
Li, M1
Li, W2
Wu, W1
Du, F1
Ji, H1
Yang, X2
Xu, Z1
Wan, L1
Wen, Q1
Cho, CH1
Zou, C1
Xiao, Z1
Liao, J1
Su, X1
Bi, Z1
Su, Q1
Huang, H1
Wei, Y2
Gao, Y2
Na, KJ1
Choi, H1
Oh, HR1
Kim, YH3
Lee, SB1
Jung, YJ1
Koh, J1
Park, S1
Lee, HJ1
Jeon, YK1
Chung, DH1
Paeng, JC1
Park, IK1
Kang, CH1
Cheon, GJ1
Kang, KW1
Lee, DS1
Kim, YT1
Pajuelo-Lozano, N1
Alcalá, S1
Sainz, B1
Perona, R1
Sanchez-Perez, I1
Logotheti, S1
Marquardt, S1
Gupta, SK1
Richter, C1
Edelhäuser, BAH1
Engelmann, D1
Brenmoehl, J1
Söhnchen, C1
Murr, N1
Alpers, M1
Singh, KP1
Wolkenhauer, O1
Heckl, D1
Spitschak, A1
Pützer, BM1
Liao, Y1
Cheng, J1
Kong, X1
Li, S1
Zhang, M4
Zhang, H1
Yang, T2
Dong, Y1
Xu, Y1
Yuan, Z1
Cao, J1
Zheng, Y1
Luo, Z1
Mei, Z1
Yao, Y1
Liang, C1
Yang, H1
Song, Y1
Zhu, C1
Huang, Z1
Qian, J1
Ge, J1
Hu, J2
Wang, H2
Liu, Y6
Mi, Y1
Kong, H1
Xi, D1
Yan, W1
Luo, X1
Ning, Q1
Chang, X2
Zhang, T2
Wang, Q2
Rathore, MG1
Reddy, K1
Shin, SH1
Ma, WY1
Bode, AM1
Dong, Z1
Mu, W1
Liu, C3
Gao, F1
Qi, Y1
Lu, H1
Zhang, X5
Cai, X1
Ji, RY1
Hou, Y3
Tian, J2
Shi, Y1
Ying, S1
Tan, M1
Feng, G1
Kuang, Y1
Chen, D1
Wu, D3
Zhu, ZQ1
Tang, HX1
Shi, ZE1
Kang, J1
Liu, Q1
Qi, J2
Mu, J1
Cong, Z1
Chen, S2
Fu, D1
Li, Z2
Celestrin, CP1
Rocha, GZ1
Stein, AM1
Guadagnini, D1
Tadelle, RM1
Saad, MJA1
Oliveira, AG1
Bianconi, V1
Bronzo, P1
Banach, M1
Sahebkar, A1
Mannarino, MR1
Pirro, M1
Patsourakos, NG1
Kouvari, M1
Kotidis, A1
Kalantzi, KI1
Tsoumani, ME1
Anastasiadis, F1
Andronikos, P1
Aslanidou, T1
Efraimidis, P1
Georgiopoulos, A1
Gerakiou, K1
Grigoriadou-Skouta, E1
Grigoropoulos, P1
Hatzopoulos, D1
Kartalis, A1
Lyras, A1
Markatos, G1
Mikrogeorgiou, A1
Myroforou, I1
Orkopoulos, A1
Pavlidis, P1
Petras, C1
Riga, M1
Skouloudi, M1
Smyrnioudis, N1
Thomaidis, K1
Tsikouri, GE1
Tsikouris, EI1
Zisimos, K1
Vavoulis, P1
Vitali, MG1
Vitsas, G1
Vogiatzidis, C1
Chantanis, S1
Fousas, S1
Panagiotakos, DB1
Tselepis, AD1
Jungen, C1
Alken, FA1
Eickholt, C1
Scherschel, K1
Kuklik, P1
Klatt, N1
Schwarzl, J1
Moser, J1
Jularic, M1
Akbulak, RO1
Schaeffer, B1
Willems, S1
Meyer, C1
Nowak, JK1
Szczepanik, M1
Trypuć, M1
Pogorzelski, A1
Bobkowski, W1
Grytczuk, M1
Minarowska, A1
Wójciak, R1
Walkowiak, J1
Lu, Y1
Xi, J1
Li, C1
Chen, W2
Hu, X1
Zhang, F1
Wei, H1
Wang, Z1
Gurzu, S1
Jung, I1
Sugimura, H2
Stefan-van Staden, RI1
Yamada, H1
Natsume, H1
Iwashita, Y1
Szodorai, R1
Szederjesi, J1
Yari, D1
Ehsanbakhsh, Z1
Validad, MH1
Langroudi, FH1
Esfandiari, H1
Prager, A1
Hassanpour, K1
Kurup, SP1
Mets-Halgrimson, R1
Yoon, H1
Zeid, JL1
Mets, MB1
Rahmani, B1
Araujo-Castillo, RV1
Culquichicón, C1
Solis Condor, R1
Efendi, F1
Sebayang, SK1
Astutik, E1
Hadisuyatmana, S1
Has, EMM1
Kuswanto, H1
Foroutan, T1
Ahmadi, F1
Moayer, F1
Khalvati, S1
Zhang, Q2
Lyu, Y1
Huang, J1
Yu, N1
Wen, Z1
Hou, H1
Zhao, T1
Gupta, A1
Khosla, N1
Govindasamy, V1
Saini, A1
Annapurna, K1
Dhakate, SR1
Akkaya, Ö1
Chandgude, AL1
Dömling, A1
Harnett, J1
Oakes, K1
Carè, J1
Leach, M1
Brown, D1
Cramer, H1
Pinder, TA1
Steel, A1
Anheyer, D1
Cantu, J1
Valle, J1
Flores, K1
Gonzalez, D1
Valdes, C1
Lopez, J1
Padilla, V1
Alcoutlabi, M1
Parsons, J1
Núñez, K1
Hamed, M1
Fort, D1
Bruce, D1
Thevenot, P1
Cohen, A1
Weber, P1
Menezes, AMB1
Gonçalves, H1
Perez-Padilla, R1
Jarvis, D1
de Oliveira, PD1
Wehrmeister, FC1
Mir, S1
Wong, J1
Ryan, CM1
Bellingham, G1
Singh, M2
Waseem, R1
Eckert, DJ1
Chung, F1
Hegde, H1
Shimpi, N1
Panny, A1
Glurich, I1
Christie, P1
Acharya, A1
English, KL1
Downs, M1
Goetchius, E1
Buxton, R1
Ryder, JW1
Ploutz-Snyder, R1
Guilliams, M1
Scott, JM1
Ploutz-Snyder, LL1
Martens, C1
Goplen, FK1
Aasen, T1
Gjestad, R1
Nordfalk, KF1
Nordahl, SHG1
Inoue, T1
Soshi, S1
Kubota, M1
Marumo, K1
Mortensen, NP1
Caffaro, MM1
Patel, PR2
Uddin, MJ1
Aravamudhan, S1
Sumner, SJ1
Fennell, TR1
Gal, RL1
Cohen, NJ1
Kruger, D1
Beck, RW1
Bergenstal, RM1
Calhoun, P1
Cushman, T1
Haban, A1
Hood, K1
Johnson, ML1
McArthur, T1
Olson, BA1
Weinstock, RS1
Oser, SM1
Oser, TK1
Bugielski, B1
Strayer, H1
Aleppo, G1
Maruyama, H1
Hirayama, K1
Yamashita, M1
Ohgi, K1
Tsujimoto, R1
Takayasu, M1
Shimohata, H1
Kobayashi, M1
Buscagan, TM1
Rees, DC1
Jaborek, JR1
Zerby, HN1
Wick, MP1
Fluharty, FL1
Moeller, SJ1
Razavi, P1
Dickler, MN1
Shah, PD1
Toy, W1
Brown, DN1
Won, HH1
Li, BT1
Shen, R1
Vasan, N1
Modi, S1
Jhaveri, K1
Caravella, BA1
Patil, S1
Selenica, P1
Zamora, S1
Cowan, AM1
Comen, E1
Singh, A1
Covey, A1
Berger, MF1
Hudis, CA1
Norton, L1
Nagy, RJ1
Odegaard, JI1
Lanman, RB1
Solit, DB1
Robson, ME1
Lacouture, ME1
Brogi, E1
Reis-Filho, JS1
Moynahan, ME1
Scaltriti, M1
Chandarlapaty, S1
Papouskova, K1
Moravcova, M1
Masrati, G1
Ben-Tal, N1
Sychrova, H1
Zimmermannova, O1
Fang, J1
Fan, Y1
Luo, T2
Su, H1
Tsetseris, L1
Anthopoulos, TD1
Liu, SF1
Zhao, K1
Sacan, O1
Turkyilmaz, IB1
Bayrak, BB1
Mutlu, O1
Akev, N1
Yanardag, R1
Gruber, S1
Kamnoedboon, P1
Özcan, M1
Srinivasan, M1
Jo, YH1
Oh, HK1
Jeong, SY1
Lee, BG1
Zheng, J1
Guan, H1
Li, D2
Tan, H1
Maji, TK1
J R, A1
Mukherjee, S1
Alexander, R1
Mondal, A1
Das, S1
Sharma, RK1
Chakraborty, NK1
Dasgupta, K1
Sharma, AMR1
Hawaldar, R1
Pandey, M1
Naik, A1
Majumdar, K1
Pal, SK1
Adarsh, KV1
Ray, SK1
Karmakar, D1
Ma, Y2
Gao, W1
Ma, S1
Lin, W1
Zhou, T1
Wu, T1
Wu, Q1
Ye, C1
He, X1
Jiang, F1
Yuan, D1
Chen, Q1
Hong, M1
Chen, K2
Hussain, M1
Razi, SS1
Yildiz, EA1
Zhao, J1
Yaglioglu, HG1
Donato, MD1
Jiang, J1
Jamil, MI1
Zhan, X1
Chen, F1
Cheng, D1
Wu, CT1
Utsunomiya, T1
Ichii, T1
Fujinami, S1
Nakajima, K1
Sanchez, DM1
Raucci, U1
Ferreras, KN1
Martínez, TJ1
Mordi, NA1
Mordi, IR1
Singh, JS1
McCrimmon, RJ1
Struthers, AD1
Lang, CC1
Wang, XW1
Yuan, LJ1
Yang, Y1
Chen, WF1
Luo, R1
Yang, K1
Amarasiri, SS1
Attanayake, AP1
Arawwawala, LDAM1
Jayatilaka, KAPW1
Mudduwa, LKB1
Ogunsuyi, O2
Akanni, O1
Alabi, O1
Alimba, C1
Adaramoye, O1
Cambier, S1
Eswara, S1
Gutleb, AC1
Bakare, A1
Gu, Z1
Cong, J1
Pellegrini, M1
Palmieri, S1
Ricci, A1
Serio, A1
Paparella, A1
Lo Sterzo, C1
Jadeja, SD1
Vaishnav, J1
Mansuri, MS1
Shah, C1
Mayatra, JM1
Shah, A1
Begum, R1
Song, H2
Lian, Y1
Wan, T1
Schultz-Lebahn, A1
Skipper, MT1
Hvas, AM1
Larsen, OH1
Hijazi, Z1
Granger, CB1
Hohnloser, SH1
Westerbergh, J1
Lindbäck, J1
Alexander, JH1
Keltai, M1
Parkhomenko, A1
López-Sendón, JL1
Lopes, RD1
Siegbahn, A1
Wallentin, L1
El-Tarabany, MS1
Saleh, AA1
El-Araby, IE1
El-Magd, MA1
van Ginkel, MPH1
Schijven, MP1
van Grevenstein, WMU1
Schreuder, HWR1
Pereira, EDM1
da Silva, J1
Carvalho, PDS1
Grivicich, I1
Picada, JN1
Salgado Júnior, IB1
Vasques, GJ1
Pereira, MADS1
Reginatto, FH1
Ferraz, ABF1
Vasilenko, EA1
Gorshkova, EN1
Astrakhantseva, IV1
Drutskaya, MS1
Tillib, SV1
Nedospasov, SA1
Mokhonov, VV1
Nam, YW1
Cui, M1
Orfali, R1
Viegas, A1
Nguyen, M1
Mohammed, EHM1
Zoghebi, KA1
Rahighi, S1
Parang, K1
Patterson, KC1
Kahanovitch, U1
Gonçalves, CM1
Hablitz, JJ1
Staruschenko, A1
Mulkey, DK1
Olsen, ML1
Gu, L1
Cao, X1
Mukhtar, A1
Wu, K2
Zhang, YY1
Zhu, Y2
Lu, DZ1
Dong, W1
Bi, WJ1
Feng, XJ1
Wen, LM1
Sun, H1
Qi, MC1
Chang, CC1
Dinh, TK1
Lee, YA1
Wang, FN1
Sung, YC1
Yu, PL1
Chiu, SC1
Shih, YC1
Wu, CY1
Huang, YD1
Lu, TT1
Wan, D1
Sakizadeh, J1
Cline, JP1
Snyder, MA1
Kiely, CJ1
McIntosh, S1
Jiang, X1
Cao, JW1
Zhao, CK1
Yang, R1
Zhang, QY1
Chen, KJ2
Liu, H1
He, Z1
Chen, B1
Wu, J1
Du, X1
Moore, J1
Blank, BR1
Eksterowicz, J1
Sutimantanapi, D1
Yuen, N1
Metzger, T1
Chan, B1
Huang, T1
Chen, X1
Duong, F1
Kong, W1
Chang, JH1
Sun, J1
Zavorotinskaya, T1
Ye, Q1
Junttila, MR1
Ndubaku, C1
Friedman, LS1
Fantin, VR1
Sun, D1
Fei, P1
Xie, Q1
Jiang, Y1
Feng, H1
Chang, Y1
Kang, H1
Xing, M1
Chen, J2
Shao, Z1
Yuan, C1
Wu, Y2
Allan, R1
Canham, K1
Wallace, R1
Singh, D1
Ward, J1
Cooper, A1
Newcomb, C1
Nammour, S1
El Mobadder, M1
Maalouf, E1
Namour, M1
Namour, A1
Rey, G1
Matamba, P1
Matys, J1
Zeinoun, T1
Grzech-Leśniak, K1
Segabinazi Peserico, C1
Garozi, L1
Zagatto, AM1
Machado, FA1
Hirth, JM1
Dinehart, EE1
Lin, YL1
Kuo, YF1
Nouri, SS1
Ritchie, C1
Volow, A1
Li, B2
McSpadden, S1
Dearman, K1
Kotwal, A1
Sudore, RL1
Ward, L1
Thakur, A1
Kondadasula, SV1
Ji, K1
Schalk, DL1
Bliemeister, E1
Ung, J1
Aboukameel, A1
Casarez, E1
Sloane, BF1
Lum, LG1
Xiao, M1
Feng, X1
Gao, R1
Du, B1
Brooks, T1
Zwirner, J1
Hammer, N1
Ondruschka, B1
Jermy, M1
Luengo, A1
Marzo, I1
Reback, M1
Daubit, IM1
Fernández-Moreira, V1
Metzler-Nolte, N1
Gimeno, MC1
Tonchev, I1
Heberman, D1
Peretz, A1
Medvedovsky, AT1
Gotsman, I1
Rashi, Y1
Poles, L1
Goland, S1
Perlman, GY1
Danenberg, HD1
Beeri, R1
Shuvy, M1
Fu, Q1
Yang, D1
Sarapulova, A1
Pang, Q1
Meng, Y1
Wei, L1
Ehrenberg, H1
Kim, CC1
Jeong, SH1
Oh, KH1
Nam, KT1
Sun, JY1
Ning, J1
Duan, Z1
Kershaw, SV1
Rogach, AL1
Gao, Z1
Wang, T1
Li, Q1
Cao, T1
Guo, L1
Fu, Y1
Seeger, ZL1
Izgorodina, EI1
Hue, S1
Beldi-Ferchiou, A1
Bendib, I1
Surenaud, M1
Fourati, S1
Frapard, T1
Rivoal, S1
Razazi, K1
Carteaux, G1
Delfau-Larue, MH1
Mekontso-Dessap, A1
Audureau, E1
de Prost, N1
Gao, SS1
Duangthip, D1
Lo, ECM1
Chu, CH1
Roberts, W1
Rosenheck, RA1
Miyake, T1
Kimoto, E1
Luo, L1
Mathialagan, S1
Horlbogen, LM1
Ramanathan, R1
Wood, LS1
Johnson, JG1
Le, VH1
Vourvahis, M1
Rodrigues, AD1
Muto, C1
Furihata, K1
Sugiyama, Y1
Kusuhara, H1
Gong, Q1
Song, W1
Sun, B1
Cao, P1
Gu, S1
Sun, X1
Zhou, G1
Toma, C1
Khandhar, S1
Zalewski, AM1
D'Auria, SJ1
Tu, TM1
Jaber, WA1
Cho, J2
Suwandaratne, NS1
Razek, S1
Choi, YH1
Piper, LFJ1
Watson, DF1
Banerjee, S1
Xie, S1
Lindsay, AP1
Bates, FS1
Lodge, TP1
Hao, Y1
Chapovetsky, A1
Liu, JJ1
Welborn, M1
Luna, JM1
Do, T1
Haiges, R1
Miller Iii, TF1
Marinescu, SC1
Lopez, SA1
Compter, I1
Eekers, DBP1
Hoeben, A1
Rouschop, KMA1
Reymen, B1
Ackermans, L1
Beckervordersantforth, J1
Bauer, NJC1
Anten, MM1
Wesseling, P1
Postma, AA1
De Ruysscher, D1
Lambin, P1
Qiang, L1
Yang, S1
Cui, YH1
He, YY1
Kumar, SK1
Jacobus, SJ1
Cohen, AD1
Weiss, M1
Callander, N1
Parker, TL1
Menter, A1
Parsons, B1
Kumar, P1
Kapoor, P1
Rosenberg, A1
Zonder, JA1
Faber, E1
Lonial, S1
Anderson, KC1
Richardson, PG1
Orlowski, RZ1
Wagner, LI1
Rajkumar, SV1
Li, G1
Hou, G1
Cui, J1
Xie, H2
Sun, Z1
Fang, Z1
Dunstand-Guzmán, E1
Hallal-Calleros, C1
Hernández-Velázquez, VM1
Canales-Vargas, EJ1
Domínguez-Roldan, R1
Pedernera, M1
Peña-Chora, G1
Flores-Pérez, I1
Kim, MJ1
Han, C1
White, K1
Park, HJ1
Boyd, K1
Rothenberger, C1
Bose, U1
Carmichael, P1
Linser, PJ1
Tanokura, M1
Salvi, R1
Someya, S1
Samuni, A1
Goldstein, S1
Divya, KP1
Dharuman, V1
Feng, J2
Qian, Y1
Cheng, Q1
Ma, H1
Ren, X1
Wei, Q1
Pan, W1
Guo, J1
Situ, B1
An, T1
Zheng, L1
Augusto, S1
Ratola, N1
Tarín-Carrasco, P1
Jiménez-Guerrero, P1
Turco, M1
Schuhmacher, M1
Costa, S1
Teixeira, JP1
Costa, C1
Syed, A1
Marraiki, N1
Al-Rashed, S1
Elgorban, AM1
Yassin, MT1
Chankhanittha, T1
Nanan, S1
Sorokina, KN1
Samoylova, YV1
Gromov, NV1
Ogorodnikova, OL1
Parmon, VN1
Ye, J1
Liao, W1
Zhang, P1
Nabi, M1
Cai, Y1
Li, F1
Alsbou, EM1
Omari, KW1
Adeosun, WA1
Asiri, AM1
Marwani, HM1
Barral, M1
Jemal-Turki, A1
Beuvon, F1
Soyer, P1
Camparo, P1
Cornud, F1
Atwater, BD1
Jones, WS1
Loring, Z1
Friedman, DJ1
Namburath, M1
Papirio, S1
Moscariello, C1
Di Costanzo, N1
Pirozzi, F1
Alappat, BJ1
Sreekrishnan, TR1
Volpin, F1
Woo, YC1
Kim, H1
Freguia, S1
Jeong, N1
Choi, JS1
Phuntsho, S1
Shon, HK1
Domínguez-Zambrano, E1
Pedraza-Chaverri, J1
López-Santos, AL1
Medina-Campos, ON1
Cruz-Rivera, C1
Bueno-Hernández, F1
Espinosa-Cuevas, A1
Bulavaitė, A1
Dalgediene, I1
Michailoviene, V1
Pleckaityte, M1
Sauerbier, P1
Köhler, R1
Renner, G1
Militz, H1
Vangaveti, S1
Das, P1
Kumar, VL1
Patel, F1
Parwani, K1
Patel, D1
Mandal, P1
Ling, S1
Shan, Q1
Liu, P1
Feng, T1
Xiang, P1
Song, P1
Liu, J1
Zheng, S1
Sun, L1
Zhong, J1
Zeng, F1
Wu, S1
Dai, J2
Liu, M1
Ai, Q2
Lin, L2
Deng, X1
Jing, Y1
Jia, M1
Wan, J2
Volarevic, V1
Misirkic, M1
Vucicevic, L1
Paunovic, V1
Simovic Markovic, B1
Stojanovic, M1
Milovanovic, M1
Jakovljevic, V1
Micic, D1
Arsenijevic, N1
Trajkovic, V1
Lukic, ML1
Bal, F1
Bekpinar, S1
Unlucerci, Y1
Kusku-Kiraz, Z1
Önder, S1
Uysal, M1
Gurdol, F1
Heidari, R1
Niknahad, H1
Jamshidzadeh, A1
Azarpira, N1
Bazyari, M1
Najibi, A1
Song, A1
Zang, S1
Song, G1
Yu, X1
Li, L2
Duan, L1
Hwang, JH2
Kim, KS1
Noh, JR2
Choi, DH1
Kim, DK1
Tadi, S1
Yim, YH1
Choi, HS1
Lee, CH2
Kaplowitz, N1
Win, S1
Than, TA1
Liu, ZX1
Dara, L1
Ramakrishna, G1
Sen, B1
Trehanpati, N1
Sarin, SK1
Cai, L1
Hu, K1
Ge, P2
Ye, B1
Neal, A1
Rountree, AM1
Philips, CW1
Kavanagh, TJ1
Williams, DP1
Newham, P1
Khalil, G1
Cook, DL1
Sweet, IR1
Zhou, K1
Pedersen, HK1
Dawed, AY1
Pearson, ER1
Saeedi Saravi, SS1
Hasanvand, A1
Shahkarami, K1
Dehpour, AR1
Du, K1
Ramachandran, A1
Weemhoff, JL1
Chavan, H1
Xie, Y1
Krishnamurthy, P1
Jaeschke, H1
de la Poza Gómez, G1
Rivero Fernández, M1
Vázquez Romero, M1
Angueira Lapeña, T1
Arranz de la Mata, G1
Boixeda de Miquel, D1
Pellegrinotti, M1
Fimognari, FL1
Franco, A1
Repetto, L1
Pastorelli, R1
Olivera-González, S1
de Escalante-Yangüela, B1
Velilla-Soriano, C1
Amores-Arriaga, B1
Martín-Fortea, P1
Navarro-Aguilar, ME1
Cone, CJ1
Bachyrycz, AM1
Murata, GH1
Yuan, H1
Zheng, W1
Hashmi, T1
Chan, KA1
Truman, A1
Gurwitz, JH1
Hurley, JS1
Martinson, B1
Platt, R1
Everhart, JE1
Moseley, RH1
Terrault, N1
Ackerson, L1
Selby, JV1
Poon, MK1
Chiu, PY1
Mak, DH1
Ko, KM1
Deutsch, M1
Kountouras, D1
Dourakis, SP1
Rajagopalan, R1
Iyer, S1
Perez, A1
Barquero Romero, J1
Pérez Miranda, M1
Kutoh, E1
Kühnau, J1
Schneider, M1
Swislocki, AL1
Noth, R1
Babich, MM1
Pike, I1
Shiffman, ML1
Crespo Valadés, E1
Ortega Gómez, A1
Alvarado Izquierdo, MI1
Magro Ledesma, D1

Reviews

4 reviews available for metformin and Chemical and Drug Induced Liver Injury

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Pr

2016
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Pharmacogenomics in diabetes mellitus: insights into drug action and drug discovery.
    Nature reviews. Endocrinology, 2016, Volume: 12, Issue:6

    Topics: Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Drug Discovery; Drug-Related Side

2016
Probable hepatotoxicity associated with the use of metformin in type 2 diabetes.
    BMJ case reports, 2011, Sep-13, Volume: 2011

    Topics: Adult; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Diagnosis, Differential; F

2011

Trials

1 trial available for metformin and Chemical and Drug Induced Liver Injury

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021

Other Studies

45 other studies available for metformin and Chemical and Drug Induced Liver Injury

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLI

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship;

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
    PLoS computational biology, 2011, Volume: 7, Issue:12

    Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da

2011
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily

2013
Metformin protects against diclofenac-induced toxicity in primary rat hepatocytes by preserving mitochondrial integrity via a pathway involving EPAC.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 143

    Topics: Animals; Antioxidants; Apoptosis; Caspase 3; Cells, Cultured; Chemical and Drug Induced Liver Injury

2021
Metformin versus silymarin as hepatoprotective agents in mice fibrotic model caused by carbon tetrachloride.
    Annales pharmaceutiques francaises, 2022, Volume: 80, Issue:5

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Liver; Liver Ci

2022
Combination of metformin and hesperidin mitigates cyclophosphamide-induced hepatotoxicity. Emerging role of PPAR-γ/Nrf-2/NF-κB signaling pathway.
    International immunopharmacology, 2023, Volume: 117

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Chemical and Drug Induced Liver Injury; Cyclophosph

2023
Evaluating the protective effect of metformin against diclofenac-induced oxidative stress and hepatic damage: In vitro and in vivo studies.
    Biochemical and biophysical research communications, 2023, 12-10, Volume: 685

    Topics: Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Diclofenac; Liver; Male; Metformin; O

2023
Metformin ameliorates acetaminophen-induced sub-acute toxicity via antioxidant property.
    Drug and chemical toxicology, 2022, Volume: 45, Issue:1

    Topics: Acetaminophen; Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Liver; Male; Metformin

2022
Metformin and silymarin afford protection in cyclosporine A induced hepatorenal toxicity in rat by modulating redox status and inflammation.
    Journal of biochemical and molecular toxicology, 2021, Volume: 35, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cyclosporine; Inflammation; Kidney Diseases; Male;

2021
Metformin and Probiotics Interplay in Amelioration of Ethanol-Induced Oxidative Stress and Inflammatory Response in an
    Mediators of inflammation, 2021, Volume: 2021

    Topics: Animals; Chemical and Drug Induced Liver Injury; Endoplasmic Reticulum Stress; Ethanol; Hep G2 Cells

2021
Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I.
    Cell death & disease, 2017, 11-02, Volume: 8, Issue:11

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line; Chemical and Dru

2017
A Turn-On Optoacoustic Probe for Imaging Metformin-Induced Upregulation of Hepatic Hydrogen Sulfide and Subsequent Liver Injury.
    Theranostics, 2019, Volume: 9, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Hydrogen Sulfide; Hypoglycemic Agents; Metformin; M

2019
Involvement of catalase in the protective benefits of metformin in mice with oxidative liver injury.
    Chemico-biological interactions, 2014, Jun-05, Volume: 216

    Topics: Animals; Carbon Tetrachloride Poisoning; Catalase; Chemical and Drug Induced Liver Injury; Enzyme-Li

2014
Metformin aggravates immune-mediated liver injury in mice.
    Archives of toxicology, 2015, Volume: 89, Issue:3

    Topics: Animals; Apoptosis; Autophagy; Chemical and Drug Induced Liver Injury; Concanavalin A; Cytokines; Fl

2015
Antidiabetic drug metformin is effective on the metabolism of asymmetric dimethylarginine in experimental liver injury.
    Diabetes research and clinical practice, 2014, Volume: 106, Issue:2

    Topics: Alanine Transaminase; Amidohydrolases; Animals; Arginine; Aspartate Aminotransferases; Chemical and

2014
Carbonyl traps as potential protective agents against methimazole-induced liver injury.
    Journal of biochemical and molecular toxicology, 2015, Volume: 29, Issue:4

    Topics: Acetylcysteine; Alanine Transaminase; Animals; Aspartate Aminotransferases; Carnosine; Chemical and

2015
Jinlida reduces insulin resistance and ameliorates liver oxidative stress in high-fat fed rats.
    Journal of ethnopharmacology, 2015, Mar-13, Volume: 162

    Topics: Animals; Chemical and Drug Induced Liver Injury; Dietary Fats; Drugs, Chinese Herbal; Hypoglycemic A

2015
Metformin ameliorates acetaminophen hepatotoxicity via Gadd45β-dependent regulation of JNK signaling in mice.
    Journal of hepatology, 2015, Volume: 63, Issue:1

    Topics: Acetaminophen; Animals; Antigens, Differentiation; Chemical and Drug Induced Liver Injury; Disease M

2015
Targeting signal transduction pathways which regulate necrosis in acetaminophen hepatotoxicity.
    Journal of hepatology, 2015, Volume: 63, Issue:1

    Topics: Animals; Antigens, Differentiation; Chemical and Drug Induced Liver Injury; JNK Mitogen-Activated Pr

2015
Repurposing of metformin in liver injury: The JNK conundrum.
    Journal of hepatology, 2016, Volume: 64, Issue:3

    Topics: Animals; Antigens, Differentiation; Chemical and Drug Induced Liver Injury; JNK Mitogen-Activated Pr

2016
AMPK dependent protective effects of metformin on tumor necrosis factor-induced apoptotic liver injury.
    Biochemical and biophysical research communications, 2015, Sep-25, Volume: 465, Issue:3

    Topics: Animals; Chemical and Drug Induced Liver Injury; Male; Metformin; Mice; Mice, Inbred BALB C; Treatme

2015
Quantification of Low-Level Drug Effects Using Real-Time, in vitro Measurement of Oxygen Consumption Rate.
    Toxicological sciences : an official journal of the Society of Toxicology, 2015, Volume: 148, Issue:2

    Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; In

2015
Reply to "Repurposing of metformin in liver injury: The JNK conundrum".
    Journal of hepatology, 2016, Volume: 64, Issue:3

    Topics: Animals; Antigens, Differentiation; Chemical and Drug Induced Liver Injury; JNK Mitogen-Activated Pr

2016
The protective potential of metformin against acetaminophen-induced hepatotoxicity in BALB/C mice.
    Pharmaceutical biology, 2016, Volume: 54, Issue:12

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Chemical and Drug Induced Liver Injury; Hypoglycem

2016
Editor's Highlight: Metformin Protects Against Acetaminophen Hepatotoxicity by Attenuation of Mitochondrial Oxidant Stress and Dysfunction.
    Toxicological sciences : an official journal of the Society of Toxicology, 2016, Volume: 154, Issue:2

    Topics: Acetaminophen; Animals; Antioxidants; Cell Line; Chemical and Drug Induced Liver Injury; Cytoprotect

2016
[Constitutional syndrome associated to metformin induced hepatotoxicity].
    Gastroenterologia y hepatologia, 2008, Volume: 31, Issue:10

    Topics: Aged, 80 and over; Chemical and Drug Induced Liver Injury; Humans; Hypoglycemic Agents; Male; Metfor

2008
Erlotinib-induced hepatitis complicated by fatal lactic acidosis in an elderly man with lung cancer.
    The Annals of pharmacotherapy, 2009, Volume: 43, Issue:3

    Topics: Acidosis, Lactic; Adenocarcinoma; Aged; Antineoplastic Agents; Chemical and Drug Induced Liver Injur

2009
[Metformin-associated hepatotoxicity].
    Medicina intensiva, 2010, Volume: 34, Issue:7

    Topics: Aged; Chemical and Drug Induced Liver Injury; Female; Humans; Hypoglycemic Agents; Metformin

2010
Hepatotoxicity associated with metformin therapy in treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease.
    The Annals of pharmacotherapy, 2010, Volume: 44, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Fatty Liver; Humans; Hypoglycemic

2010
Antidiabetic drug metformin alleviates endotoxin-induced fulminant liver injury in mice.
    International immunopharmacology, 2012, Volume: 12, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Caspases; Chemical and Drug Induced Liver Injury; Gala

2012
A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents.
    Archives of internal medicine, 2003, Mar-24, Volume: 163, Issue:6

    Topics: Acute Disease; Adult; Aged; Chemical and Drug Induced Liver Injury; Chromans; Cohort Studies; Female

2003
Metformin protects against carbon tetrachloride hepatotoxicity in mice.
    Journal of pharmacological sciences, 2003, Volume: 93, Issue:4

    Topics: Alanine Transaminase; Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injur

2003
Metformin hepatotoxicity.
    Annals of internal medicine, 2004, Mar-02, Volume: 140, Issue:5

    Topics: Aged; Chemical and Drug Induced Liver Injury; Female; Humans; Hypoglycemic Agents; Metformin

2004
Comparison of pioglitazone with other antidiabetic drugs for associated incidence of liver failure: no evidence of increased risk of liver failure with pioglitazone.
    Diabetes, obesity & metabolism, 2005, Volume: 7, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Chemical and Drug Induced Liver In

2005
[Metformin-induced cholestatic hepatitis].
    Gastroenterologia y hepatologia, 2005, Volume: 28, Issue:4

    Topics: Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Female; Humans; Hypoglycemic Agents

2005
Possible metformin-induced hepatotoxicity.
    The American journal of geriatric pharmacotherapy, 2005, Volume: 3, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agen

2005
[Metformin in combination therapy of diabetes mellitus. Advantages and reservations].
    Deutsche medizinische Wochenschrift (1946), 1983, Jul-15, Volume: 108, Issue:28-29

    Topics: Acidosis; Chemical and Drug Induced Liver Injury; Diabetes Mellitus; Drug Therapy, Combination; Huma

1983
Fatal hepatic necrosis following cardiac surgery and enflurane anaesthesia.
    Anaesthesia and intensive care, 1996, Volume: 24, Issue:2

    Topics: Acidosis, Lactic; Anesthesia, Inhalation; Anesthetics, Inhalation; Cardiac Surgical Procedures; Chem

1996
Case report. Pseudohepatotoxicity of metformin.
    Diabetes care, 1998, Volume: 21, Issue:4

    Topics: Aged; Alanine Transaminase; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Dia

1998
Metformin-induced acute hepatitis.
    The American journal of medicine, 1998, Volume: 104, Issue:5

    Topics: Acute Disease; Alanine Transaminase; Alkaline Phosphatase; Bilirubin; Biopsy; Chemical and Drug Indu

1998
[Hepatotoxic reaction associated with metformin and chlorpropamide treatment].
    Revista clinica espanola, 1999, Volume: 199, Issue:2

    Topics: Aged; Chemical and Drug Induced Liver Injury; Chlorpropamide; Cholestasis; Diabetes Mellitus, Type 2

1999